Literature DB >> 19526246

Kinetics of retinal vaso-obliteration and neovascularisation in the oxygen-induced retinopathy (OIR) mouse model.

C Lange1, C Ehlken, A Stahl, G Martin, L Hansen, H T Agostini.   

Abstract

PURPOSE: To evaluate the kinetics of peripheral vascularisation, central vessel regression and neovascularisation in the OIR mouse model in order to: i) generate standard kinetics for further studies in this model, and ii) define optimal time points to investigate cellular mechanisms of retinal vascular plasticity.
METHODS: From postnatal day 7 (P7) until P12, newborn mice were kept at 75% oxygen. The animals were sacrificed on different time points, during and after O(2) exposure. After intracardial perfusion with FITC-dextran, retinal flatmounts were prepared, and the size of the retinal vascular network, the size of the central avascular area, and the number of blood vessel tufts and clusters were determined. In addition to the fluorescein stain for perfused capillaries, endothelial cells were stained with isolectin.
RESULTS: Upon O(2) exposure, there is a rapid depletion of capillaries starting adjacent to the large central arteries. These avascular stripes fuse to form an avascular central area which amounts to 37% of the whole retinal surface after 2 days of hyperoxia. The peripheral capillary network remains intact throughout the incubation period, even though the pace of its centrifugal spreading is decelerated compared to room air controls. Already during O(2) exposure, revascularisation of the central avascular area is initiated by peripheral vessels sprouting in a centripetal direction. Revascularisation is accelerated after the return to room air, and is completed at P25. Maximal pathological neovascularisation can be found at P17, at the border between the avascular and vascular retina.
CONCLUSION: Hyperoxia leads to a rapid development of a central avascular area of the retina, with its maximum during not at the end of the hyperoxic phase. Central capillary loss and peripheral vascularisation take place simultaneously, indicating different cellular control mechanisms for different areas of the retina. These standard kinetics for peripheral vascularisation and central vessel regression will: 1) help to compare the effects of angio-modulation, and 2) serve as normal baseline for the characterization of knock-out mice strains with regard to gene-specific vascular changes in the OIR-model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19526246     DOI: 10.1007/s00417-009-1116-4

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  34 in total

1.  Retinal vascularization in health and disease: Proctor Award Lecture of the Association for Research in Ophthalmology.

Authors:  N ASHTON
Journal:  Am J Ophthalmol       Date:  1957-10       Impact factor: 5.258

Review 2.  Ocular neovascularization: an epidemiologic review.

Authors:  P Lee; C C Wang; A P Adamis
Journal:  Surv Ophthalmol       Date:  1998 Nov-Dec       Impact factor: 6.048

3.  Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in mice.

Authors:  Philip Maier; Anke S Unsoeld; Bernd Junker; Gottfried Martin; Joachim Drevs; Lutz L Hansen; Hansjürgen T Agostini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-01-14       Impact factor: 3.117

4.  Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy.

Authors:  Tom A Gardiner; David S Gibson; Tanyth E de Gooyer; Vidal F de la Cruz; Denise M McDonald; Alan W Stitt
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

5.  The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity.

Authors:  Ronen Rabinowitz; Gabriel Katz; Mordechai Rosner; Sara Pri-Chen; Abraham Spierer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-03-15       Impact factor: 3.117

6.  Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.

Authors:  E A Pierce; E D Foley; L E Smith
Journal:  Arch Ophthalmol       Date:  1996-10

7.  Oxygen-induced retinopathy in the mouse.

Authors:  L E Smith; E Wesolowski; A McLellan; S K Kostyk; R D'Amato; R Sullivan; P A D'Amore
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-01       Impact factor: 4.799

8.  Rifampicin inhibits the retinal neovascularization in vitro and in vivo.

Authors:  Yuichi Chikaraishi; Nozomu Matsunaga; Masamitsu Shimazawa; Hideaki Hara
Journal:  Exp Eye Res       Date:  2007-10-14       Impact factor: 3.467

9.  Role of arteries in oxygen induced vaso-obliteration.

Authors:  Suzanne Claxton; Marcus Fruttiger
Journal:  Exp Eye Res       Date:  2003-09       Impact factor: 3.467

10.  A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.

Authors:  L E Benjamin; I Hemo; E Keshet
Journal:  Development       Date:  1998-05       Impact factor: 6.868

View more
  32 in total

Review 1.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

Review 2.  Animal models of ocular angiogenesis: from development to pathologies.

Authors:  Chi-Hsiu Liu; Zhongxiao Wang; Ye Sun; Jing Chen
Journal:  FASEB J       Date:  2017-07-24       Impact factor: 5.191

3.  Assessment of vascular regeneration in the CNS using the mouse retina.

Authors:  Khalil Miloudi; Agnieszka Dejda; François Binet; Eric Lapalme; Agustin Cerani; Przemyslaw Sapieha
Journal:  J Vis Exp       Date:  2014-06-23       Impact factor: 1.355

4.  Effect of brimonidine on retinal and choroidal neovascularization in a mouse model of retinopathy of prematurity and laser-treated rats.

Authors:  Jyotirmoy Kusari; Edwin Padillo; Sheila X Zhou; Yanyan Bai; Juanjuan Wang; Zhiming Song; Meili Zhu; Yun-Zheng Le; Daniel W Gil
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-20       Impact factor: 4.799

5.  NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.

Authors:  Jennifer L Wilkinson-Berka; Devy Deliyanti; Indrajeetsinh Rana; Antonia G Miller; Alex Agrotis; Roksana Armani; Cédric Szyndralewiez; Kirstin Wingler; Rhian M Touyz; Mark E Cooper; Karin A Jandeleit-Dahm; Harald H H W Schmidt
Journal:  Antioxid Redox Signal       Date:  2013-10-30       Impact factor: 8.401

6.  Norrin treatment improves ganglion cell survival in an oxygen-induced retinopathy model of retinal ischemia.

Authors:  Wendy A Dailey; Kimberly A Drenser; Sui Chien Wong; Mei Cheng; Joseph Vercellone; Kevin K Roumayah; Erin V Feeney; Mrinalini Deshpande; Alvaro E Guzman; Michael Trese; Kenneth P Mitton
Journal:  Exp Eye Res       Date:  2017-08-18       Impact factor: 3.467

7.  MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathy.

Authors:  Zhenhua Xu; Junsong Gong; Debasish Maiti; Linh Vong; Lijuan Wu; John J Schwarz; Elia J Duh
Journal:  Am J Pathol       Date:  2012-04-19       Impact factor: 4.307

8.  Erythropoietin Receptor Signaling Supports Retinal Function after Vascular Injury.

Authors:  Colin A Bretz; Aaron B Simmons; Eric Kunz; Aniket Ramshekar; Carson Kennedy; Ivan Cardenas; M Elizabeth Hartnett
Journal:  Am J Pathol       Date:  2020-02-21       Impact factor: 4.307

9.  [Pathogenesis of retinopathy of prematurity].

Authors:  A Stahl; W A Lagrèze; H T Agostini
Journal:  Ophthalmologe       Date:  2012-12       Impact factor: 1.059

10.  Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.

Authors:  Ka Ka Ting; Yang Zhao; Weiyong Shen; Paul Coleman; Michelle Yam; Tailoi Chan-Ling; Jia Li; Thorleif Moller; Mark Gillies; Mathew A Vadas; Jennifer R Gamble
Journal:  Diabetologia       Date:  2018-11-15       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.